Characterization and Clinical Implications of p53 Dysfunction in Patients With Myelodysplastic SyndromesMatteo Zampini, Matteo Giovanni Della Porta, Elena Riva et al.|Journal of Clinical Oncology|2025Cited by 13
Enhancing Personalized Prognostic Assessment of Myelodysplastic Syndromes through a Multimodal and Explainable Deep Data Fusion Approach (MAGAERA)Elisabetta Sauta, Matteo Giovanni Della Porta, Saverio D’Amico et al.|Blood|2024Cited by 2
Artificial Intelligence-Powered Digital Pathology to Improve Diagnosis and Personalized Prognostic Assessment in Patient with Myeloid NeoplasmsGianluca Asti, Matteo Giovanni Della Porta, Alessandra Crespi et al.|Blood|2024Cited by 1